Invention Grant
- Patent Title: Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
-
Application No.: US16276540Application Date: 2019-02-14
-
Publication No.: US11260053B2Publication Date: 2022-03-01
- Inventor: Bronislava Gedulin , Andrew A. Young , Howard E. Greene
- Applicant: Satiogen Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Satiogen Pharmaceuticals, Inc.
- Current Assignee: Satiogen Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/575
- IPC: A61K31/575 ; A61K31/496 ; A61K9/00 ; A61K9/02 ; A61K9/28 ; A61K31/155 ; A61K31/16 ; A61K31/18 ; A61K31/19 ; A61K31/191 ; A61K31/216 ; A61K31/38 ; A61K31/40 ; A61K31/42 ; A61K31/452 ; A61K31/454 ; A61K31/495 ; A61K31/4985 ; A61K31/4995 ; A61K31/513 ; A61K31/5377 ; A61K31/55 ; A61K31/554 ; A61K31/655 ; A61K31/7042 ; A61K45/06 ; C07C279/14 ; C07D295/13 ; C07D401/12 ; C07D487/08
Abstract:
Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
Public/Granted literature
Information query
